Momelotinib During and After HCT in Myelofibrosis

Clinical trial NCT07104799 · RECRUITING

Trial details

NCT number: NCT07104799
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myelofibrosis Hematopoietic Cell Transplantation (HCT)

Start date: 2026-02-23
Primary completion: 2028-01-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.